Corporate Responsibilities for Access to Medicines

Journal of Business Ethics 85 (S1):3 - 23 (2009)

Abstract

Today there is a growing wave of demands being placed upon the pharmaceutical industry to contribute to improved access to medicines for poor patients in the developing countries. 1 This article aims to contribute to the development of a systematic approach and broad consensus about shared benchmarks for good corporate practices in this area. A consensus corridor on what constitutes an appropriate portfolio of corporate responsibilities for access to medicines -especially under conditions of 'failing states' and 'market failure' 2 – is not only in the interest of the world's poor, but also of corporations that want to contribute to the solution of one of the most significant social problems of our time

Download options

PhilArchive



    Upload a copy of this work     Papers currently archived: 72,694

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Analytics

Added to PP
2009-01-28

Downloads
44 (#261,325)

6 months
1 (#388,319)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Similar books and articles